Uncategorized

FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation — New Drug Approvals

FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation First drug granted approval under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, instituted to spur development of antibiotics for unmet medical needs The U.S. Food and Drug Administration today approved a new drug, Arikayce […]

via FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation — New Drug Approvals

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s